NFKB1 and cancer: Mangiferin dramatically eradicates the nuclear evacuation of the NF‐κB subunits, p65 and p50, diminishes NF‐κB activity, and reduces TNF‐α‐induced MMP‐9 activity in androgen‐sensitive individuals with LNCaP (lymph node carcinoma of the prostate) cancer cells.